Global Novel Drug Delivery Systems (NDDS) Market Research Report 2023: A $61 Billion Market by 2030 - Nanotechnology Bolsters Demand

News provided by

May 10, 2023, 10:30 ET

DUBLIN, May 10, 2023 /PRNewswire/ -- The "Novel Drug Delivery Systems (NDDS): Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Global Novel Drug Delivery Systems (NDDS) Market to Reach $61 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Novel Drug Delivery Systems (NDDS) estimated at US$12.7 Billion in the year 2022, is projected to reach a revised size of US$61 Billion by 2030, growing at a CAGR of 21.6% over the analysis period 2022-2030.

Nanoparticles, one of the segments analyzed in the report, is projected to record 21.1% CAGR and reach US$48.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Embolization Particles segment is readjusted to a revised 23.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $4.8 Billion, While China is Forecast to Grow at 26.4% CAGR

The Novel Drug Delivery Systems (NDDS) market in the U.S. is estimated at US$4.8 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$7.4 Billion by the year 2030 trailing a CAGR of 26.4% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.7% and 19.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 20.2% CAGR.

Looking Ahead to 2023

Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year.

Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.

Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

What`s New for 2023?

Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and Research Platform
Complimentary updates for one year

MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
An Insight into Pandemic Impact on Pharmaceuticals Industry
COVID-19 & Other Factors Shift Focus to Different Drug Delivery Approaches
Novel Drug Delivery Systems Gain Interest Amid the Fight Against COVID-19
Nanomaterial-enabled Novel Drug Delivery Systems Gain Interest in Vaccine Development
Novel Drug Delivery System (NDDS): A Prelude
Versatile Benefits of NDDS Drive Companies to Embrace the Drug Delivery Approach
Patient Compliance: A Key Reason Garnering Interest in NDD
Regulatory Process for Novel Drug Delivery Systems
A Look into Current Areas of Research in Drug Delivery
Market Outlook
Nanotechnology-Enabled Drug Delivery: Primary Challenges
Recent Market Activity

MARKET TRENDS & DRIVERS

Nanotechnology Bolsters Demand for NDDS
Prospects Remain Encouraging
Microfluidics Mediated NDDS Set to Make Gains
Nanocarriers Enable Targeted Drug Delivery Systems to Improve Therapeutic Outcomes
Advanced Liposomes Enable Low Soluble Drugs to Achieve Targeted Delivery
List of Marketed Liposome-Based Clinical Products Classified by Therapeutic Areas
Liposomes-based Drug Delivery Systems to touch Diverse Areas of Modern Medicine
Dendrimers as Ideal Drug Delivery Agents
List of Commercially Available Dendrimeric Products by Application Area
High Drug Loading Capacity of PAMAM Dendrimers Bodes Well for Targeted Drug Delivery Systems
Oral Thin Films Enhance NDDS Domain
Nanotechnology-Enabled Drug Delivery Opens New Horizons to Improve Cancer Treatments
Rising Cancer Incidence Drives Focus onto Novel Drug Delivery Mechanisms
Novel Drug Delivery System Emerges as a Potential Treatment for Pediatric Brain Tumors
Uptrend in Gene Therapy Market Augurs Well for Market Growth
Adeno-Associated Virus Vectors: A Leading Platform for Gene Therapy
Application of Nanotechnology-based Drug Delivery Systems for CVD Treatment
NDD for Antimicrobial Drugs
List of Select Nanotechnology-based Antimicrobial Drugs in Clinical Use
Nanotechnology Opens New Avenues in Antiretroviral Therapy
Demonstrated Activity of Select Nanotechnology-Delivered Antiretroviral Therapies
Novel Drug Delivery System Exhibits Potential to Target HIV Reservoirs
Global HIV Prevalence Seeks Need for Novel Drug Delivery Systems
Novel Drug Delivery Systems for CNS Therapeutics
Novel Drug and a New Delivery Method for Restoring Brain Cells in People Suffering from PD
Nanotechnology Powers Next Wave of Change for Neglected Tropical Diseases' Treatment
Novel Drug Delivery Systems Hold Edge over Existing Therapies for Diabetic Retinopathy
Exciting Immunology Developments Involving Graphene-based Nanomaterials
Nanotechnology-Based Strategies for siRNA Grows in Popularity
Nanoemulsions Begin to Make a Mark
Inorganic Nanocarriers Facilitate High Payload Capacity and Co-Delivery Platforms for MDR Cancer Therapy
Solid Lipid Nanoparticles Provide Increased Physical Stability in Targeted Drug Delivery
Recent Advancements in Polymeric Drug Delivery Systems
Pulmonary Delivery of Nanoparticle-Based Drugs Receives Increased Interest
Inhalable Liposome Formulations Attract Research Interest in Pulmonary Delivery
SLNs in Pulmonary Delivery of Drugs
Other Nanocarriers in Pulmonary Delivery
Increasing Importance of Gold Nanoparticles in Targeted Drug Administration
Gold Nanoparticles Open New Avenues in Combinatorial Cancer Therapy
Consistent Rise in Healthcare Spending Worldwide to Drive Market Opportunities

FOCUS ON SELECT PLAYERS (Total 238 Featured)

AstraZeneca PLC
Boston Scientific Corporation
Cospheric LLC
EmboMedics, Inc.
F. Hoffmann-La Roche AG
Merit Medical Systems, Inc.
Mo-Sci Corporation
Polysciences, Inc.
Sirtex Medical Inc.
Terumo Medical Corporation

For more information about this report visit https://www.researchandmarkets.com/r/a3iq5e

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets